Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Neurology
2
Pipeline Programs
1
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Bayer
BayerLEVERKUSEN, Germany
2 programs
2
BAY1817080Phase 21 trial
BAY2395840Phase 23 trials
Active Trials
NCT04641273Terminated154Est. Oct 2021
NCT05406219Withdrawn0Est. Oct 2023
NCT05563454Completed24Est. Feb 2023
+1 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BayerBAY2395840
BayerBAY1817080
BayerBAY2395840
BayerBAY2395840

Clinical Trials (4)

Total enrollment: 258 patients across 4 trials

A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain

Start: Feb 2022Est. completion: Nov 202280 patients
Phase 2Completed

A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic Pain

Start: Jan 2021Est. completion: Oct 2021154 patients
Phase 2Terminated

A Study to Learn How the Study Treatment BAY2395840 Moves Into, Through and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Moderate Reduced Kidney Function and in Healthy Male and Female Participants With Normal Kidney Function

Start: May 2023Est. completion: Oct 20230
Phase 1Withdrawn

A Study to Learn How Safe the Study Treatment BAY2395840 is, How it Affects the Body and How it Moves Into, Through, and Out of the Body if Given in Single and in Repetitive Doses to Japanese Healthy Male Participants

Start: Oct 2022Est. completion: Feb 202324 patients
Phase 1Completed

Related Jobs in Neurology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space